Douglas Hunt
General Counsel at PUMA BIOTECHNOLOGY, INC.
Net worth: 305 116 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Bradway | M | 61 | 18 years | |
| Alan Auerbach | M | 54 | 14 years | |
| Michael Miller | M | 67 | 6 years | |
| Robert Eckert | M | 69 | 21 years | |
| Mathias Schmidt | M | 56 |
ArmaGen, Inc.
 ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | 8 years |
| Maximo Nougues | M | 55 | 6 years | |
| Brian Stuglik | M | 64 | 4 years | |
| Esteban Santos | M | 56 | 17 years | |
| Allison Dorval | F | 48 | 3 years | |
| David Reese | M | 61 | 19 years | |
| Troy Wilson | M | 55 | 11 years | |
| Adrian Senderowicz | M | 60 | 9 years | |
| Alessandra Cesano | M | 63 | 2 years | |
| Jay Moyes | M | 70 | 12 years | |
| Matthew Busch | M | 50 | 20 years | |
| Mariann Ohanesian | F | - | - | |
| Derek Miller | M | - | 21 years | |
| Mike Zahigian | M | - | 23 years | |
| Jeffrey Ludwig | M | 58 | 4 years | |
| Alvin Wong | M | 71 | 11 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Charles R. Eyler | M | 76 | 8 years | |
| Pamela Wapnick | F | 58 | 9 years | |
| Paul Eisenberg | M | - | 14 years | |
| David W. Beier | M | 75 | 10 years | |
| Michael Kelly | M | 67 | 14 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| Dennis Fenton | M | 72 | 27 years | |
| Ann Miller | M | 66 | 8 years | |
| Amy Pott | F | 47 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 11 years |
| William Ashton | M | 73 | 16 years | |
| Jim Callaway | M | - |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | 4 years |
| Frank J. Biondi | M | 79 | 15 years | |
| Preston Klassen | M | 55 | 7 years | |
| Sean B. W. Martin | M | 61 | - | |
| John Moriarty | M | 56 | 6 years | |
| Nathan Hardy | M | 48 | 10 years | |
| Diana McKenzie | F | 59 | 12 years | |
| Sean E. Harper | M | 61 | 16 years | |
| Gregory L. Tewalt | M | - | - | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| James Callaway | M | 68 |
ArmaGen, Inc.
ArmaGen, Inc. Hospital/Nursing ManagementHealth Services ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA. | 4 years |
| Michael Severino | M | 58 | 10 years | |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Andreas Grauer | M | 63 | - | |
| Cynthia Flowers | F | 64 | 5 years | |
| Craig Shepherd | M | - | 7 years | |
| Cynthia Patton | F | 62 | 15 years | |
| Erin Lavelle | F | 46 | 15 years | |
| Thomas Zindrick | M | 65 | 8 years | |
| Willard Dere | M | 70 | 11 years | |
| Hugh O'Dowd | M | 59 | 2 years | |
| Joseph Newell | M | 54 | 7 years | |
| William P. Sheridan | M | 69 | 5 years | |
| Leonard Schaeffer | M | 78 | 9 years | |
| James Daly | M | 62 | 9 years | |
| Robert Davis | M | 57 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 6 years |
| George Morrow | M | 72 | 10 years | |
| David J. Scott | M | 71 | - | |
| Brian M. McNamee | M | 67 | - | |
| Timothy Martin | M | 55 | 3 years | |
| Dominique Monnet | M | 65 | 11 years | |
| Frank Herringer | M | 81 | 15 years | |
| Vance D. Coffman | M | 79 | 9 years | |
| Anna Richo | F | 63 | 9 years | |
| J. Reason | M | 83 | 12 years | |
| Frank Zavrl | M | 58 | 5 years | |
| Patricia Cary Sueltz | F | 71 | 2 years | |
| Jin Long Chen | M | 61 | 4 years | |
| John Smither | M | 71 | 6 years | |
| Scott W. Meacham | M | 64 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | 8 years |
| Joshua J. Ofman | M | 60 | 16 years | |
| Diane Parks | F | 71 | 7 years | |
| David A. Boyden | M | 63 | 13 years | |
| Susan R. Lundeen-Smuck | F | 58 | 9 years | |
| Edward A. Imbrogno | M | 60 | 7 years | |
| Stephen Blackwood | M | 61 | 7 years | |
| Stuart Tross | M | 57 | 10 years | |
| Brian Kotzin | M | 74 | 11 years | |
| Bradley J. Maroni | M | 71 | 6 years | |
| Catherine Stehman-Breen | M | 61 | 12 years | |
| Peter K. Watler | M | 62 | 12 years | |
| Nick Abbott | M | - | 10 years | |
| James Scott Whitehurst | M | 58 | 8 years | |
| Yi Ning Zhao | M | 53 | 5 years | |
| Timothy Powers | M | 58 | 5 years | |
| Brian Lian | M | - | 3 years | |
| George Morstyn | M | 73 | 11 years | |
| James G. Stout | M | 58 | 4 years | |
| Terry Rosen | M | 65 | 9 years | |
| Marc D. Better | M | 68 | 5 years | |
| William Marshall | M | 60 | 10 years | |
| Urte Gayko | M | 53 | 9 years | |
| Jesse Seton McGreivy | M | 54 | 6 years | |
| Michael Narachi | M | 64 | 20 years | |
| David Hallal | M | 56 | 10 years | |
| Majed Kheir | M | 46 | 6 years | |
| Steven J. Ruhl | M | - | - | |
| Andrew Knudten | M | - | 13 years | |
| Richard Davies | M | 62 | 9 years | |
| Frederick A. Fletcher | M | - | 10 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas Hunt
- Personal Network
